prnewswire.comESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction3 days ago
prnewswire.comESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 20252 months ago
prnewswire.comEPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit4 months ago
prnewswire.comEPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm4 months ago
prnewswire.comEPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit4 months ago
prnewswire.comEPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm4 months ago
prnewswire.comEPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit4 months ago
prnewswire.comSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma4 months ago
prnewswire.comLevi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EPIX4 months ago
prnewswire.comEPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm4 months ago
CashuESSA Bancorp Enters Strategic Acquisition Agreement with XenoTherapeutics for Future Growth1 day ago
CashuESSA Bancorp Acquires XenoTherapeutics to Enhance Shareholder Value and Streamline Operations3 days ago
CashuESSA Bancorp Announces Acquisition Agreement with XenoTherapeutics for Shareholder Value Enhancement5 days ago